Raising the Bar in PV Care

Before joining Corazon’s team of experts, I was fortunate to spend my last clinical assignment in a peripheral-vascular lab. Our services covered PAD (peripheral artery disease), but we also cared for a huge population of renal fistula/catheter patients. Due to the reoccurrence of problems involved with renal access sites, our renal patients returned on a…

Initial Considerations for Successful PCI Program Expansion to Open Heart Surgery

Many hospitals nationwide have seen the benefits of expanding invasive cardiac services to include PCI (percutaneous coronary intervention) without open heart surgery on-site.   Although these hospitals have the opportunity to provide advanced interventional cardiac care, they are limited as per the SCAI/ACC/AHA Expert Consensus Document:  Update on Percutaneous Coronary Intervention Without On-Site Surgical Backup that…

Optimizing your TAVR Program

A recent article in Circulation, published online ahead of print, addressed a retrospective cohort study using data from the STS/ACC TVT Registry which concluded that significant differences in the quality of TAVR care exists, particularly, variations in mortality and major complications after TAVR procedures in the United States (Desai et al, 2021). The study also…

Advocating for our Healthcare

Working in the industry, whether as a clinician at the patient bedside; in Administration or a Quality, Finance, or Ancillary Department; as a supply or equipment vendor; or in healthcare consulting, we can all relate to the importance of patient advocacy and the reason behind why many of us have chosen to join the remarkable…

The Business Case for TAVR

WHY TAVR? When TAVR first emerged, this procedure was primarily performed in academic, quaternary, tertiary-type centers. But as time goes on, more and more community-based open-heart centers are offering TAVR as well. There is no question that TAVR is growing at a rapid pace, but there are many more entrants into the market. At Corazon…